These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12088277)

  • 21. Phosphoinositide signaling disorders in human diseases.
    Pendaries C; Tronchère H; Plantavid M; Payrastre B
    FEBS Lett; 2003 Jul; 546(1):25-31. PubMed ID: 12829232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The physiology of phosphoinositides.
    Sasaki T; Sasaki J; Sakai T; Takasuga S; Suzuki A
    Biol Pharm Bull; 2007 Sep; 30(9):1599-604. PubMed ID: 17827706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphoinositides in the regulation of actin cortex and cell migration.
    Tsujita K; Itoh T
    Biochim Biophys Acta; 2015 Jun; 1851(6):824-31. PubMed ID: 25449647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
    Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
    Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench.
    Wishart MJ; Taylor GS; Slama JT; Dixon JE
    Curr Opin Cell Biol; 2001 Apr; 13(2):172-81. PubMed ID: 11248551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of phosphoinositide signaling by the inositol polyphosphate 5-phosphatases.
    Astle MV; Seaton G; Davies EM; Fedele CG; Rahman P; Arsala L; Mitchell CA
    IUBMB Life; 2006 Aug; 58(8):451-6. PubMed ID: 16916781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphoinositides at the neuromuscular junction of Drosophila melanogaster: a genetic approach.
    Slabbaert JR; Khuong TM; Verstreken P
    Methods Cell Biol; 2012; 108():227-47. PubMed ID: 22325606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of phosphoinositide metabolism by pathogenic bacteria.
    Hilbi H
    Cell Microbiol; 2006 Nov; 8(11):1697-706. PubMed ID: 16939534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups.
    Downes CP; Gray A; Fairservice A; Safrany ST; Batty IH; Fleming I
    Biochem Soc Trans; 2005 Dec; 33(Pt 6):1303-7. PubMed ID: 16246104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoinositides: lipid kinases and phosphatases.
    Payrastre B
    Methods Mol Biol; 2004; 273():201-12. PubMed ID: 15308803
    [No Abstract]   [Full Text] [Related]  

  • 31. Modeling, dynamics and phosphoinositide binding of the pleckstrin homology domain of two novel PLCs: η1 and η2.
    Rai S; Mohanty P; Bhatnagar S
    J Mol Graph Model; 2018 Oct; 85():130-144. PubMed ID: 30193228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Membrane targeting and remodeling through phosphoinositide-binding domains.
    Takenawa T; Itoh T
    IUBMB Life; 2006; 58(5-6):296-303. PubMed ID: 16754321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of the phosphoinositides at the Golgi complex.
    De Matteis MA; D'Angelo G
    Biochem Soc Symp; 2007; (74):107-16. PubMed ID: 17233584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphoinositides and cellular pathogens.
    Payrastre B; Gaits-Iacovoni F; Sansonetti P; Tronchère H
    Subcell Biochem; 2012; 59():363-88. PubMed ID: 22374097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
    Ramos AR; Elong Edimo W; Erneux C
    Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho GTPases, phosphoinositides, and actin: a tripartite framework for efficient vesicular trafficking.
    Croisé P; Estay-Ahumada C; Gasman S; Ory S
    Small GTPases; 2014; 5():e29469. PubMed ID: 24914539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of Phosphoinositide Molecular Species in Resting or Activated Human or Mouse Platelets by a LC-MS Method.
    Chicanne G; Bertrand-Michel J; Viaud J; Hnia K; Clark J; Payrastre B
    Methods Mol Biol; 2021; 2251():39-53. PubMed ID: 33481230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
    Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
    J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphoinositide turnover in Toll-like receptor signaling and trafficking.
    Le OT; Nguyen TT; Lee SY
    BMB Rep; 2014 Jul; 47(7):361-8. PubMed ID: 24856829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease.
    Ramos AR; Ghosh S; Erneux C
    J Lipid Res; 2019 Feb; 60(2):276-286. PubMed ID: 30194087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.